Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high‐molecular‐weight cytokeratin expression patterns
- 28 September 2001
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 195 (4) , 415-421
Abstract
According to current concepts, benign proliferative breast disease (BPBD) is a direct precursor of breast cancer, in a spectrum ranging from ductal hyperplasia to overtly invasive carcinoma. In this study, comparative genomic hybridization (CGH) was used to screen ductal hyperplasia and other BPBD lesions and ductal carcinoma in situ (DCIS) for common genomic abnormalities, to test the relationship between these hyperplastic and neoplastic lesions. Immunohistochemistry for cytokeratin 5/6 was used as a diagnostic adjunct to distinguish ductal hyperplasia from DCIS. A total of 42 cases of BPBD comprising ductal hyperplasia of the usual type (n=14), papilloma (n=22), tubular adenoma (n=3), and adenosis (n=3), as well as 52 cases of DCIS, were studied. All cases of BPBD consistently displayed the presence of a subpopulation of cytokeratin 5/6‐expressing basal‐type cells within the proliferative lesion, whereas all of the non‐high‐grade and most of the high‐grade DCIS lesions lacked cytokeratin 5/6‐positive cells. Whereas gross genomic alterations, as determined by CGH, were undetectable in BPBD, distinct genetic changes characterized all cases of DCIS, with one exception. These results confirm the usefulness of cytokeratin 5/6 immunohistology in the diagnosis of BPBD and neoplastic breast lesions and support the view that BPBD and DCIS are not closely related entities and that BPBD is not an obligate direct precursor of DCIS. Copyright © 2001 John Wiley & Sons, Ltd.Keywords
This publication has 32 references indexed in Scilit:
- The Photographic Atlas of Practical Anatomy.Journal of Clinical Pathology, 2000
- Abnormal regulation of the oestrogen receptor in benign breast lesionsJournal of Clinical Pathology, 2000
- Loss of Heterozygosity in Fibrocystic Change of the BreastThe American Journal of Pathology, 2000
- Transforming Growth Factor-β and Breast Cancer Risk in Women With Mammary Epithelial HyperplasiaJNCI: Journal of the National Cancer Institute, 1999
- Use of Keratin 34βE12 as an Adjunct in the Diagnosis of Mammary Intraepithelial Neoplasia-Ductal Type—Benign and Malignant Intraductal ProliferationsAmerican Journal of Surgical Pathology, 1999
- Radial Scars in Benign Breast-Biopsy Specimens and the Risk of Breast CancerNew England Journal of Medicine, 1999
- Comparative genomic hybridisation of ductal carcinoma in situ of the breast: identification of regions of DNA amplification and deletion in common with invasive breast carcinomaOncogene, 1997
- Loss of Heterozygosity in Normal Tissue Adjacent to Breast CarcinomasScience, 1996
- Consistency of histopathological reporting of breast lesions detected by screening: Findings of the U.K. National External Quality Assessment (EQA) schemeEuropean Journal of Cancer, 1994
- Portfolio learning in palliative medicineEuropean Journal of Cancer Care, 1993